https://www.statnews.com/2026/04/06/fda-delay-cited-in-closure-kezar-life-sciences-biotech-startup/
FDA delay cited in closure of biotech studying autoimmune hepatitis
Apr 6, 2026 - By the time FDA agreed to meet with Kezar Life Sciences it was in the process of closing. The chain of events fits a pattern of FDA volatility recently.
autoimmune hepatitisfdadelaycitedclosure